Difference between revisions of "CT Coordinating Committee"

From QIBA Wiki
Jump to: navigation, search
m
Line 1: Line 1:
 
__NOTOC__
 
__NOTOC__
:Chairs: Rudresh Jarecha, MBBS, DNB, DMRE (Co-Chair), Jenifer Siegelman, MD, MPH (Co-Chair), and David Lynch, MD (Vice-chair)
+
:Chairs: Rudresh Jarecha, MBBS, DNB, DMRE (Co-Chair), Jenifer Siegelman, MD, MPH (Co-Chair), Andrew J. Buckler, MS (Co-Chair)
 
:RSNA Staff Support: Julie Lisiecki   
 
:RSNA Staff Support: Julie Lisiecki   
 
* [http://tinyurl.com/QIBA-CT-CC-Roster Roster]
 
* [http://tinyurl.com/QIBA-CT-CC-Roster Roster]

Revision as of 21:53, 4 January 2021

Chairs: Rudresh Jarecha, MBBS, DNB, DMRE (Co-Chair), Jenifer Siegelman, MD, MPH (Co-Chair), Andrew J. Buckler, MS (Co-Chair)
RSNA Staff Support: Julie Lisiecki


Scope

The CT Coordinating Committee coordinates Biomarker Committees based on CT.

  • Considering and proposing new candidate Biomarker Committees to the Steering Committee
  • Preparing/Reviewing and Prioritizing groundwork funding proposals for submission to the Steering Committee
  • Approving for publication Biomarker Profiles developed by the CT Biomarker Committees

Meetings

  • WebEx calls are held Quarterly. Please contact RSNA Staff for details.